Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1190-1192
Number of pages3
JournalMultiple Sclerosis
Volume23
Issue number9
DOIs
StatePublished - Aug 1 2017

Fingerprint

Therapeutics

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

@article{3270a824ebb54fa58b044f86665e8f45,
title = "Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO",
author = "William Tobin and Weinshenker, {Brian G}",
year = "2017",
month = "8",
day = "1",
doi = "10.1177/1352458517702556",
language = "English (US)",
volume = "23",
pages = "1190--1192",
journal = "Multiple Sclerosis",
issn = "1352-4585",
publisher = "SAGE Publications Ltd",
number = "9",

}

TY - JOUR

T1 - Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS – NO

AU - Tobin, William

AU - Weinshenker, Brian G

PY - 2017/8/1

Y1 - 2017/8/1

UR - http://www.scopus.com/inward/record.url?scp=85026631998&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026631998&partnerID=8YFLogxK

U2 - 10.1177/1352458517702556

DO - 10.1177/1352458517702556

M3 - Article

AN - SCOPUS:85043310718

VL - 23

SP - 1190

EP - 1192

JO - Multiple Sclerosis

JF - Multiple Sclerosis

SN - 1352-4585

IS - 9

ER -